Product Categories
Country: | United States |
---|---|
Tel: | 781-+1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
Meropenem trihydrate;SM 7338 trihydrate | C17H27N3O6S | 119478-56-7 | Details |
Methoxy-PEPy | C13H10N2O | 524924-76-3 | Details |
m-Tyramine hydrobromide | C8H12BrNO | 38449-59-1 | Details |
Mexiletine-d6 hydrochloride;KOE-1173 D6 hydrochloride;Mexiletine D6 hydrochloride | C11H18ClNO | 1329835-60-0 | Details |
MEN11467 | C38H40N4O3 | 214487-46-4 | Details |
Mitotane;Mitotan;o,p'-DDD;2,4′-DDD;NCI-C04933 | C14H10Cl4 | 53-19-0 | Details |
Methyl homoveratrate | C11H14O4 | 15964-79-1 | Details |
MF 5137 | C23H23N3O3 | 148927-23-5 | Details |
Masupirdine free base;SUVN-502 free base | C21H24BrN3O3S | 701205-60-9 | Details |
MBM-55 | C28H27FN6O2 | 2083622-09-5 | Details |
PROTAC Mcl1 degrader-1 | C45H45BrN6O8S | 2163793-38-0 | Details |
MCL-1/BCL-2-IN-2 | C20H15BrN2O2S | 2163793-44-8 | Details |
MBM-17S | C32H34N6O6 | 2083621-91-2 | Details |
Meluadrine tartrate | C16H24ClNO8 | 134865-37-5 | Details |
Meloxicam-d3;Meloxicam D4 | C14H13N3O4S2 | 942047-63-4 | Details |
MethADP;Adenosine 5'-(α,β-methylene)diphosphate | C11H17N5O9P2 | 3768-14-7 | Details |
Tetracaine hydrochloride;Amethocalne HCl;Amethocaine hydrochloride;Tetracaine HCl | C15H25ClN2O2 | 136-47-0 | Details |
O-desmethyl Mebeverine acid;Mebeverine metabolite O-desmethyl Mebeverine acid | C15H23NO3 | 586357-02-0 | Details |
McN3716;Methyl palmoxirate;NSC359682 | C18H34O3 | 69207-52-9 | Details |
m-Tyramine | C8H11NO | 588-05-6 | Details |
Mebeverine D6 Hydrochloride | C25H36ClNO5 | 1329647-20-2 | Details |
MARK-IN-1 | C22H23F2N7OS | 1109283-93-3 | Details |
MGAT2-IN-1 | C27H21ClF5N7O3S | 1800025-30-2 | Details |
Malic enzyme inhibitor ME1;ME1 | C20H21N3O3 | 522649-59-8 | Details |
MDL 19301 | C15H21NS2 | 89388-38-5 | Details |
Nadolol;SQ11725;Solgol;Corgard;Anabet | C17H27NO4 | 42200-33-9 | Details |
MAPK13-IN-1 | C20H23N5O2 | 229002-10-2 | Details |
MD-224 | C48H43Cl2FN6O6 | 2136247-12-4 | Details |
Methyl L-pyroglutamate;L-Pyroglutamic acid methyl ester;(S)-Methyl 5-oxopyrrolidine-2-carboxylate | C6H9NO3 | 4931-66-2 | Details |
MDM2-IN-1 | C23H21Cl2FN2O3 | 1410737-09-5 | Details |
Manitimus;FK778 | C15H11F3N2O2 | 202057-76-9 | Details |
MAT2A inhibitor 2 | C18H24ClN3O3 | 13299-99-5 | Details |
MGAT2-IN-2 | C26H21F5N4O4S | 1710630-11-7 | Details |
Mcl-1 antagonist 1 | C41H54ClF2N5O8S | 2376775-05-0 | Details |
MBM-55S | C32H33FN6O6 | 2083624-07-9 | Details |
Melagatran | C22H31N5O4 | 159776-70-2 | Details |
MG 1 | C17H25N3O2 | 148274-76-4 | Details |
Sulpiride;Aiglonyl;Dobren;Dolmatil;Sulpyrid;Dogmatil | C15H23N3O4S | 15676-16-1 | Details |
Mavoglurant;AFQ056 | C19H23NO3 | 543906-09-8 | Details |
Methylnaltrexone-d3 bromide;Methylnaltrexone D3 Bromide | C21H26BrNO4 | 1131456-47-7 | Details |
Mcl1-IN-9 | C37H39ClN4O4 | 1810769-31-3 | Details |
MCL-1/BCL-2-IN-4 | C26H23BrN2O5S | 2163793-56-2 | Details |
MARK-IN-2 | C18H18ClF2N5OS | 1314893-26-9 | Details |
Macropa-NCS | C27H35N5O8S | 2146095-31-8 | Details |
Metofenazate;Methophenazine | C31H36ClN3O5S | 388-51-2 | Details |
O-Desmethyl Mebeverine alcohol;Mebeverine metabolite O-desmethyl Mebeverine alcohol | C15H25NO2 | 155172-67-1 | Details |
meta-Fexofenadine;meta-MDL-16455;meta-Terfenadine carboxylate | C32H39NO4 | 479035-75-1 | Details |
Mavoglurant racemate;AFQ-056 racemate | C19H23NO3 | 1636881-61-2 | Details |
MELK-8a hydrochloride | C25H33ClN6O | 2096992-20-8 | Details |
Trimebutine maleate;Polibutin;Debridat | C26H33NO9 | 34140-59-5 | Details |
MB-07344 | C19H25O5P | 852947-39-8 | Details |
MethADP sodium salt | C11H18N5NaO9P2 | 89016-30-8 | Details |
Melatonin-d4;N-Acetyl-5-methoxytryptamine D5;Melatonin D5 | C13H12D4N2O2 | 66521-38-8 | Details |
Menin-MLL inhibitor 4 | C32H38FN7O3 | 2169916-13-4 | Details |
Mebeverine alcohol;Mebeverine metabolite Mebeverine alcohol | C16H27NO2 | 14367-47-6 | Details |
Methyl carnosate | C21H30O4 | 82684-06-8 | Details |
Methyl 3-O-methylgallate;M3OMG | C9H10O5 | 3934-86-9 | Details |
Macitentan-d4;ACT-064992 D4;Macitentan D4 | C19H16Br2D4N6O4S | 1258428-05-5 | Details |
Telomerase-IN-1 | C21H23FN2O4 | 666859-49-0 | Details |
Cotinine;S-(-)-Cotinine;(-)-Cotinine;(S)-Cotinine;NIH-10498 | C10H12N2O | 486-56-6 | Details |
MF-094 | C30H37N3O4S | 2241025-68-1 | Details |
Mefentrifluconazole | C18H15ClF3N3O2 | 1417782-03-6 | Details |
MBC-11 trisodium | C11H21N3NaO14P3 | 387877-45-4 | Details |
MCB-3681 | C31H32F2N4O8 | 790704-42-6 | Details |
MBM-17 | C28H28N6O2 | 2083621-90-1 | Details |
Mcl1-IN-12 | C45H46N4O6S2 | 2042211-12-9 | Details |
MBC-11 | C11H20N3O14P3 | 332863-86-2 | Details |
Mefuparib hydrochloride;MPH | C17H16ClFN2O2 | 1449746-00-2 | Details |
MCHR1 antagonist 3 | C29H36N4O2 | 1069622-60-1 | Details |
Methimazole D3 | C4H6N2S | 1160932-07-9 | Details |
Menaquinone-7;Vitamin K2(35);Vitamin K2-7;Vitamin MK-7 | C46H64O2 | 2124-57-4 | Details |
MAC13772 | C8H9N3O3S | 4871-40-3 | Details |
Macitentan (n-butyl analogue) | C20H21Br2N5O4S | 556797-16-1 | Details |
MCH-1 antagonist 1 | C25H26N4O2 | 1039825-68-7 | Details |
MDRTB-IN-1 | C15H18N2O3 | 1973401-05-6 | Details |
Mcl1-IN-11 | C38H41N3O5S2 | 2042211-13-0 | Details |
MCL-1/BCL-2-IN-3 | C27H25BrN2O5S | 2163793-55-1 | Details |
MA242 | C26H21ClF3N3O5S | 1049704-18-8 | Details |
MAP4K4-IN-3;Compound 17 | C15H12ClN5 | 1811510-58-3 | Details |
MAGL-IN-1 | C22H24FNO3 | 2324160-91-8 | Details |
Meclofenamic acid;Meclofenamate | C14H11Cl2NO2 | 644-62-2 | Details |
MEK inhibitor | C26H26N4O2 | 334951-92-7 | Details |
Mensacarcin | C21H24O9 | 808750-39-2 | Details |
Mebeverine acid D5 | C16H25NO3 | 2070015-30-2 | Details |
Mcl1-IN-4 | C28H26N2O5S | 1580484-04-3 | Details |
Metarrestin;ML246 | C31H30N4O | 1443414-10-5 | Details |
Mebeverine acid;Mebeverine metabolite Mebeverine acid | C16H25NO3 | 475203-77-1 | Details |
MFZ 10-7 hydrochloride | C15H10ClFN2 | 1779796-36-9 | Details |
McN5691;RWJ26240 | C30H35NO3 | 99254-95-2 | Details |
Metronidazole Benzoate;Benzoyl metronidazole | C13H13N3O4 | 13182-89-3 | Details |
MB-07729 | C12H15N2O5PS | 882755-95-5 | Details |
Methylproamine | C28H31N7 | 188247-01-0 | Details |
Maritoclax;Marinopyrrole A | C22H12Cl4N2O4 | 1227962-62-0 | Details |
Aurora B inhibitor 1 | C25H26ClF2N7O2 | 937276-52-3 | Details |
Masupirdine mesylate;SUVN-502 mesylate | C22H28BrN3O6S2 | 1791396-46-7 | Details |
MCHR1 antagonist 2 | C23H21FN2O5 | 863115-70-2 | Details |
Methyllycaconitine citrate;MLA | C43H58N2O17 | 351344-10-0 | Details |
MELK-IN-1;MELK inhibitor 17;Nintedanib Impurity L | C31H33N5O4 | 2095596-44-2 | Details |
Mcl-1 inhibitor 3 | C40H52ClF2N5O7S | 2376774-73-9 | Details |
Metixene hydrochloride | C20H23NS.ClH | 1553-34-0 | Details |
Product Total: Product Page: | ||||
11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 |